Peg-INF

Name: Peg-INF
Company: BF Biosciences Limited
Therapeutic Segment: HEPATOLOGY
Area: Hepatitis-C
Description:
Peg-INF (Pegylated Interferon Alpha 2a 180 mcg – 40KD) is available in vials containing 1 ml ready-to-inject solution. Peginterferon is part of a once-weekly regimen indicated in the treatment of chronic Hepatitis C in combination with Ribavirin.
TOP